Rakha E, Tse G, Quinn C
Histopathology. 2022; 82(1):5-16.
PMID: 36482272
PMC: 10108289.
DOI: 10.1111/his.14786.
Espelund U, Renehan A, Cold S, Oxvig C, Lancashire L, Su Z
Cancer Med. 2018; 7(6):2391-2404.
PMID: 29722920
PMC: 6010701.
DOI: 10.1002/cam4.1504.
Esbah O, Oksuzoglu B
Indian J Med Res. 2018; 146(5):563-571.
PMID: 29512598
PMC: 5861467.
DOI: 10.4103/ijmr.IJMR_1354_17.
Dodson A, Okonji D, Assersohn L, Rigg A, Sheri A, Turner N
Breast Cancer Res Treat. 2017; 168(1):249-258.
PMID: 29128896
PMC: 5847032.
DOI: 10.1007/s10549-017-4514-z.
Rejali M, Tazhibi M, Mokarian F, Gharanjik N, Mokarian R
Int J Prev Med. 2015; 6:93.
PMID: 26605014
PMC: 4629295.
DOI: 10.4103/2008-7802.166503.
Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.
Purdie C, Quinlan P, Jordan L, Ashfield A, Ogston S, Dewar J
Br J Cancer. 2013; 110(3):565-72.
PMID: 24300977
PMC: 3915123.
DOI: 10.1038/bjc.2013.756.
Usefulness of serum CA 15.3 and histopathological prognostic indices in breast cancer.
Nalini R, Wilma Delphine Silvia C, Makhija P, Uthappa S
Indian J Clin Biochem. 2012; 20(1):165-8.
PMID: 23105517
PMC: 3454159.
DOI: 10.1007/BF02893065.
External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.
Hajage D, De Rycke Y, Bollet M, Savignoni A, Caly M, Pierga J
PLoS One. 2011; 6(11):e27446.
PMID: 22087319
PMC: 3210791.
DOI: 10.1371/journal.pone.0027446.
Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
Campbell H, Gray A, Harris A, Briggs A, Taylor M
Br J Cancer. 2010; 103(6):776-86.
PMID: 20823886
PMC: 2966633.
DOI: 10.1038/sj.bjc.6605863.
An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
Campbell H, Taylor M, Harris A, Gray A
Br J Cancer. 2009; 101(7):1074-84.
PMID: 19724274
PMC: 2768087.
DOI: 10.1038/sj.bjc.6605283.
[Prognostic and predictive factors of invasive breast cancer: update 2009].
Decker T, Hungermann D, Bocker W
Pathologe. 2009; 30(1):49-55.
PMID: 19184022
DOI: 10.1007/s00292-008-1105-0.
Prognosis based on primary breast carcinoma instead of pathological nodal status.
Menard S, Bufalino R, RILKE F, Cascinelli N, Veronesi U, Colnaghi M
Br J Cancer. 1994; 70(4):709-12.
PMID: 7917924
PMC: 2033423.
DOI: 10.1038/bjc.1994.379.
A prognostic index in primary breast cancer.
Haybittle J, Blamey R, Elston C, Johnson J, DOYLE P, Campbell F
Br J Cancer. 1982; 45(3):361-6.
PMID: 7073932
PMC: 2010939.
DOI: 10.1038/bjc.1982.62.
The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects.
Elston C, GRESHAM G, Rao G, ZEBRO T, Haybittle J, Houghton J
Br J Cancer. 1982; 45(5):655-69.
PMID: 7044401
PMC: 2011009.
DOI: 10.1038/bjc.1982.106.
Review of general surgery 1979.
Ellis H
Postgrad Med J. 1980; 56(655):305-21.
PMID: 7003568
PMC: 2425627.
DOI: 10.1136/pgmj.56.655.305.
Morphometric analysis of breast carcinoma: association with survival.
Parham D, Robertson A, BROWN R
J Clin Pathol. 1988; 41(2):173-7.
PMID: 2832452
PMC: 1141374.
DOI: 10.1136/jcp.41.2.173.
Expression of epidermal growth factor receptor in breast carcinoma.
Lewis S, Locker A, Todd J, Bell J, Nicholson R, Elston C
J Clin Pathol. 1990; 43(5):385-9.
PMID: 2370306
PMC: 502437.
DOI: 10.1136/jcp.43.5.385.
Assessment of milk fat globule membrane antibodies and lectins as markers of short-term prognosis in breast cancer.
Walker R
Br J Cancer. 1990; 62(3):462-6.
PMID: 2206956
PMC: 1971445.
DOI: 10.1038/bjc.1990.319.
A sequence previously identified as metastasis-related encodes an acidic ribosomal phosphoprotein, P2.
Sharp M, Adams S, Elvin P, Walker R, Brammar W, Varley J
Br J Cancer. 1990; 61(1):83-8.
PMID: 2153399
PMC: 1971331.
DOI: 10.1038/bjc.1990.19.
The Nottingham Prognostic Index in primary breast cancer.
Galea M, Blamey R, Elston C, Ellis I
Breast Cancer Res Treat. 1992; 22(3):207-19.
PMID: 1391987
DOI: 10.1007/BF01840834.
